Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;13:100140.
doi: 10.1016/j.clinpr.2022.100140. Epub 2022 Feb 16.

Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review

Affiliations
Free PMC article
Review

Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review

Mohammed Qutub et al. Clin Infect Pract. 2022 Jan.
Free PMC article

Abstract

Background: The duration of viable viral shedding is important to be defined in regards of viral transmission in SARS-CoV-2 infection with the backdrop of the current worldwide effort for revising isolation polices and establishing the duration of infectiousness.

Methods: In this review we searched databases including Medline and google scholar for research articles published between January 2020 and January 2022. We included case reports, case series, cross sectional, cohort, and randomized control trials that reported the duration of shedding of viable SARS-CoV-2 virus. After evaluating the criteria for inclusion, 32 articles (2721 patients) were included.

Result: This review showed that the median for the last day of successful viral isolation was 11 (8.5-14.5 95% CI) , 20 (9.0-57.5 95 %CI), 20 (9.0-103 95 %CI) for the general population, critical patients and immunocompromised individuals, respectively, with significant association between prolonged viral shedding, disease severity (P-Value 0.024) and immunosuppressive status (P-Value 0.023).The corresponding higher cutoff of CTv to culturable virus ranged between 26.25 and 34.00 (95% confidence interval) with median of 30.5, and higher values were observed when critical (25.0-37.37 95 %CI) and immunocompromised patients (20.0-37.82 95 %CI) have been excluded, this deviation did not represent a statistical significance (P-Value 0.997 and 0.888) respectively.

Conclusion: Our review highlights that repeating SARS-CoV-2 viral RNA test solely in recovering patients has no importance in determining infectivity and emphasizes the individualization of de-isolation decisions based on the host factors and a combined symptom and testing-based approaches with the later benefiting most of correlation with recently introduced rapid antigen test. Our finding in the review also opposes the most recent CDC Guidance on shortening isolation duration in term of the last days of viable transmissible virus, therefore caution should be considered when revising such protocols.

Keywords: COVID-19; CTv, Cycle thresholdvalue; Cycle threshold value; Isolation; PCR; RAT, Rapid antigen test; RT-PCR, Reverse transcription polymerase chain reaction; Transmission; Viral culture.

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Prisma Algorithm for database search and article selection.

Similar articles

References

    1. Albert E., Torres I., Bueno F., Huntley D., Molla E., Fernández-Fuentes M.Á., et al. Field evaluation of a rapid antigen test (PanbioTM covid-19 ag rapid test device) for COVID-19 diagnosis in primary healthcare centres. Clin. Microbiol. Infect. 2021;27(3):472.e7–472.e10. - PMC - PubMed
    1. Alshukairi A.N., Tolah A.M., Dada A., Al-Tawfiq J.A., Almagharbi R.S., Saeedi M.F., et al. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture. Int. J. Infectious Diseases. 2021;108:112–115. - PMC - PubMed
    1. AMA: CDC quarantine and isolation guidance is confusing, counterproductive [Internet]. American Medical Association. [cited 2022 Jan 8]. Available from: https://www.ama-assn.org/press-center/press-releases/ama-cdc-quarantine-....
    1. Asrani P., Eapen M.S., Chia C., Haug G., Weber H.C., Hassan M.I., Sohal S.S. Diagnostic approaches in COVID-19: clinical updates. Expert Rev. Respiratory Med. 2021;15(2):197–212. - PubMed
    1. Basile K, McPhie K, Carter I, Alderson S, Rahman H, Donovan L, et al. Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19. Clin Infect Dis. 2020 Oct 24;ciaa1579. - PMC - PubMed

LinkOut - more resources